Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
Some issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/2/198 |
id |
doaj-185f08c1818a4286b98c6e175436e47a |
---|---|
record_format |
Article |
spelling |
doaj-185f08c1818a4286b98c6e175436e47a2021-02-03T00:02:37ZengMDPI AGPharmaceutics1999-49232021-02-011319819810.3390/pharmaceutics13020198Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production TechnologiesSabrina Bochicchio0Gaetano Lamberti1Anna Angela Barba2Eng4Life Srl, Spin-Off Accademico, Via Fiorentino, 32, 83100 Avellino, ItalyEng4Life Srl, Spin-Off Accademico, Via Fiorentino, 32, 83100 Avellino, ItalyEng4Life Srl, Spin-Off Accademico, Via Fiorentino, 32, 83100 Avellino, ItalySome issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are required to overcome production limitations (low productivity, high energy consumption, expensive setup, long process times) to pass at the industrial level. In this paper, a summary of applications of polymeric and lipid materials combined as nanostructures (hybrid nanocarriers) is reported. Then, recent techniques adopted in the production of hybrid nanoparticles are discussed, highlighting limitations still present that hold back the industrial implementation.https://www.mdpi.com/1999-4923/13/2/198polymerslipidshybrid nanoparticlesnanotechnologiesproduction technologiesdrug delivery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sabrina Bochicchio Gaetano Lamberti Anna Angela Barba |
spellingShingle |
Sabrina Bochicchio Gaetano Lamberti Anna Angela Barba Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies Pharmaceutics polymers lipids hybrid nanoparticles nanotechnologies production technologies drug delivery |
author_facet |
Sabrina Bochicchio Gaetano Lamberti Anna Angela Barba |
author_sort |
Sabrina Bochicchio |
title |
Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies |
title_short |
Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies |
title_full |
Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies |
title_fullStr |
Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies |
title_full_unstemmed |
Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies |
title_sort |
polymer–lipid pharmaceutical nanocarriers: innovations by new formulations and production technologies |
publisher |
MDPI AG |
series |
Pharmaceutics |
issn |
1999-4923 |
publishDate |
2021-02-01 |
description |
Some issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are required to overcome production limitations (low productivity, high energy consumption, expensive setup, long process times) to pass at the industrial level. In this paper, a summary of applications of polymeric and lipid materials combined as nanostructures (hybrid nanocarriers) is reported. Then, recent techniques adopted in the production of hybrid nanoparticles are discussed, highlighting limitations still present that hold back the industrial implementation. |
topic |
polymers lipids hybrid nanoparticles nanotechnologies production technologies drug delivery |
url |
https://www.mdpi.com/1999-4923/13/2/198 |
work_keys_str_mv |
AT sabrinabochicchio polymerlipidpharmaceuticalnanocarriersinnovationsbynewformulationsandproductiontechnologies AT gaetanolamberti polymerlipidpharmaceuticalnanocarriersinnovationsbynewformulationsandproductiontechnologies AT annaangelabarba polymerlipidpharmaceuticalnanocarriersinnovationsbynewformulationsandproductiontechnologies |
_version_ |
1724290365452713984 |